Advisory Committee on Breast Cancer in Young Women (ACBCYW), 18601 [2013-06946]
Download as PDF
<![CDATA[
18601
Federal Register / Vol. 78, No. 59 / Wednesday, March 27, 2013 / Notices
For Form 2: Antimicrobial
Susceptibility Testing, the annual
frequency of responses per respondent
is 1,452 (121 isolates × 12 months).
Based on previous laboratory
experience, the estimated burden of
completing Form 2 for each
participating laboratory is 1 hour per
response, which includes the time
required for laboratory processing of the
patient’s isolate, gathering and
maintaining the data needed, and
completing and reviewing the collection
of information. For Form 3: Control
Strain Susceptibility Testing, a
‘‘response’’ is defined as the processing
and recording of Regional laboratory
data for a set of seven control strains. It
takes approximately 12 minutes to
process and record the Regional
laboratory data on Form 3 for one set of
seven control strains, of which there are
4 sets. The number of responses per
respondent is 48 (4 sets × 12 months).
There are no additional costs to
respondents.
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Avg. burden
per response
(in hours)
Total annual
burden
(in hours)
Type of respondent
Form name
Clinic ..............................
Laboratory ......................
Demographic Clinical Data Form 1 .....................
Antimicrobial Susceptibility Testing Form 2 ........
Control Strain Susceptibility Testing Form 3 .......
30
5
5
240
1,452
48
11/60
1
12/60
1,320
7,260
48
Total ........................
..............................................................................
40
........................
........................
8,628
Dated: March 21, 2013.
Ron A. Otten,
Director, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2013–07059 Filed 3–26–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Advisory Committee on Breast Cancer
in Young Women (ACBCYW)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 9:00 a.m.–11:00 a.m.
EDT, April 16, 2013.
Place: The meeting will be held via
teleconference.
Teleconference login information is as
follows: For Public:
TOLL–FREE PHONE #: 800–857–4875
Participant passcode: 9377
Net Conference URL: https://
www.mymeetings.com/nc/join/
Conference number: PW8921926
Audience passcode: 9377 or Public
can join the event directly: https://
www.mymeetings.com/nc/
join.php?i=PW8921926&p=9377&t=c
There is also a toll number for anyone
outside of the USA:
TOLL #: 1–212–287–1661
Participant passcode: 9377
Please go to the ACBCYW meeting
Web page to register for this meeting:
https://www.cdc.gov/cancer/breast/
what_cdc_is_doing/conference.htm.
VerDate Mar<15>2010
18:10 Mar 26, 2013
Jkt 229001
Status: Open to the public, limited
only by the number of phone lines
available.
Purpose: The committee provides
advice and guidance to the Secretary,
HHS; the Assistant Secretary for Health;
and the Director, CDC, regarding the
formative research, development,
implementation and evaluation of
evidence-based activities designed to
prevent breast cancer (particularly
among those at heightened risk) and
promote the early detection and support
of young women who develop the
disease. The advice provided by the
Committee will assist in ensuring
scientific quality, timeliness, utility, and
dissemination of credible appropriate
messages and resource materials.
Matters To Be Discussed: The agenda
will include discussions on approaches
to increase awareness of clinicians/
practitioners regarding topics such as
breast health, symptoms, diagnosis, and
treatment of breast cancer in young
women; and information needs and
delivery mechanisms for women at
higher risks for developing breast
cancer. These discussions will be
directed toward the final review and
approval of formal recommendations on
these topics.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Temeika L. Fairley, Ph.D., Designated
Federal Officer, National Center for
Chronic Disease Prevention and Health
Promotion, CDC, 4770 Buford Highway
NE., Mailstop K52, Atlanta, Georgia,
30341, Telephone (770) 488–4518, Fax
(770) 488–4760, Email:
acbcyw@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and Agency for Toxic
Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–06946 Filed 3–26–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Respirator Certification Fees; Public
Meeting
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of public meeting.
AGENCY:
SUMMARY: The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces a public meeting. The
purpose of this meeting is to allow
stakeholders to present information the
impact of an increase on respirator fees
on individual respirator manufacturers,
the respirator market, or on those
industries that rely on NIOSH approved
respiratory equipment.
DATES: April 30, 2013, 10 a.m. to 4 p.m.
EDT, or after the last public commenter
has spoken, whichever occurs first.
ADDRESSES: U.S. Office of Surface
Mining, Three Parkway Center
E:\FR\FM\27MRN1.SGM
27MRN1
]]>Agencies
[Federal Register Volume 78, Number 59 (Wednesday, March 27, 2013)]
[Notices]
[Page 18601]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-06946]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Breast Cancer in Young Women (ACBCYW)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date: 9:00 a.m.-11:00 a.m. EDT, April 16, 2013.
Place: The meeting will be held via teleconference.
Teleconference login information is as follows: For Public:
TOLL-FREE PHONE #: 800-857-4875
Participant passcode: 9377
Net Conference URL: https://www.mymeetings.com/nc/join/
Conference number: PW8921926
Audience passcode: 9377 or Public can join the event directly:
https://www.mymeetings.com/nc/join.php?i=PW8921926&p=9377&t=c
There is also a toll number for anyone outside of the USA:
TOLL #: 1-212-287-1661
Participant passcode: 9377
Please go to the ACBCYW meeting Web page to register for this
meeting: https://www.cdc.gov/cancer/breast/what_cdc_is_doing/conference.htm.
Status: Open to the public, limited only by the number of phone
lines available.
Purpose: The committee provides advice and guidance to the
Secretary, HHS; the Assistant Secretary for Health; and the Director,
CDC, regarding the formative research, development, implementation and
evaluation of evidence-based activities designed to prevent breast
cancer (particularly among those at heightened risk) and promote the
early detection and support of young women who develop the disease. The
advice provided by the Committee will assist in ensuring scientific
quality, timeliness, utility, and dissemination of credible appropriate
messages and resource materials.
Matters To Be Discussed: The agenda will include discussions on
approaches to increase awareness of clinicians/practitioners regarding
topics such as breast health, symptoms, diagnosis, and treatment of
breast cancer in young women; and information needs and delivery
mechanisms for women at higher risks for developing breast cancer.
These discussions will be directed toward the final review and approval
of formal recommendations on these topics.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Temeika L. Fairley, Ph.D.,
Designated Federal Officer, National Center for Chronic Disease
Prevention and Health Promotion, CDC, 4770 Buford Highway NE., Mailstop
K52, Atlanta, Georgia, 30341, Telephone (770) 488-4518, Fax (770) 488-
4760, Email: acbcyw@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and Agency for
Toxic Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2013-06946 Filed 3-26-13; 8:45 am]
BILLING CODE 4163-18-P
